Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning GE Schafe, CM Atkins, MW Swank, EP Bauer, JD Sweatt, JE LeDoux Journal of Neuroscience 20 (21), 8177-8187, 2000 | 771 | 2000 |
Regulation of dendritic morphogenesis by Ras–PI3K–Akt–mTOR and Ras–MAPK signaling pathways V Kumar, MX Zhang, MW Swank, J Kunz, GY Wu Journal of Neuroscience 25 (49), 11288-11299, 2005 | 689 | 2005 |
Protein kinase modulation of dendritic K+ channels in hippocampus involves a mitogen-activated protein kinase pathway LL Yuan, JP Adams, M Swank, JD Sweatt, D Johnston Journal of Neuroscience 22 (12), 4860-4868, 2002 | 362 | 2002 |
Increased histone acetyltransferase and lysine acetyltransferase activity and biphasic activation of the ERK/RSK cascade in insular cortex during novel taste learning MW Swank, JD Sweatt Journal of Neuroscience 21 (10), 3383-3391, 2001 | 234 | 2001 |
c-Fos induction in response to a conditioned stimulus after single trial taste aversion learning MW Swank, IL Bernstein Brain research 636 (2), 202-208, 1994 | 174 | 1994 |
c-Fos induction in response to taste stimuli previously paired with amphetamine or LiCl during taste aversion learning MW Swank, GE Schafe, IL Bernstein Brain research 673 (2), 251-261, 1995 | 128 | 1995 |
Protein kinase signal transduction cascades in mammalian associative conditioning JC Selcher, EJ Weeber, AW Varga, JD Sweatt, M Swank The Neuroscientist 8 (2), 122-131, 2002 | 115 | 2002 |
Phosphorylation of ERK/MAP kinase is required for long-term potentiation in anatomically restricted regions of the lateral amygdala in vivo GE Schafe, MW Swank, SM Rodrigues, J Dȩbiec, V Doyère Learning & Memory 15 (2), 55-62, 2008 | 79 | 2008 |
Phosphorylation of MAP kinase and CREB in mouse cortex and amygdala during taste aversion learning MW Swank Neuroreport 11 (8), 1625-1630, 2000 | 68 | 2000 |
c-Fos antisense blocks acquisition and extinction of conditioned taste aversion in mice MW Swank, AE Ellis, BN Cochran Neuroreport 7 (11), 1866-1870, 1996 | 68 | 1996 |
Ca2+ permeation and/or binding to CaV1.1 fine-tunes skeletal muscle Ca2+ signaling to sustain muscle function CS Lee, A Dagnino-Acosta, V Yarotskyy, A Hanna, A Lyfenko, ... Skeletal muscle 5, 1-16, 2015 | 51 | 2015 |
Personal hydration system for runners MW Swank US Patent 6,666,360, 2003 | 50 | 2003 |
Gene expression profiling and functional proteomic analysis reveal perturbed kinase-mediated signaling in genetic stroke susceptibility M Fornage, MW Swank, E Boerwinkle, PA Doris Physiological genomics 15 (1), 75-83, 2003 | 34 | 2003 |
Coordinate regulation of Fos and Jun proteins in mouse brain by LiCl MW Swank Neuroreport 10 (17), 3685-3689, 1999 | 31 | 1999 |
Conditioned c-Fos in mouse NTS during expression of a learned taste aversion depends on contextual cues MW Swank Brain research 862 (1-2), 138-144, 2000 | 20 | 2000 |
Characterization of a 3H-arginine8-vasopressin binding site in the cingulate gyrus of the rat pup P Szot, KM Myers, M Swank, DM Dorsa Peptides 10 (6), 1231-1237, 1989 | 20 | 1989 |
Pharmacological antagonism of tyrosine kinases and MAP kinase in brainstem blocks taste aversion learning in mice MW Swank Physiology & behavior 69 (4-5), 499-503, 2000 | 19 | 2000 |
Evidence for glucocorticoid regulation of the rat vasopressin V1a receptor gene JJ Watters, MW Swank, CW Wilkinson, DM Dorsa Peptides 17 (1), 67-73, 1996 | 17 | 1996 |
Chronic treatment with vasopressin analogues alters affinity of vasopressin receptors in the septum and amygdala of the rat brain MW Swank, DM Dorsa Brain research 544 (2), 342-344, 1991 | 16 | 1991 |
Routes of non-traditional entry into buprenorphine treatment programs T Champagne-Langabeer, MW Swank, JR Langabeer Substance Abuse Treatment, Prevention, and Policy 15, 1-10, 2020 | 14 | 2020 |